Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment
Apr 05, 2021
New Delhi (India) [India], April 5 : Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.